Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Healthcare startup Otter Health launched with $8M in seed funding, aiming to replace traditional prior authorization with an AI-powered platform that gives payers and providers a shared, real-time view of clinical decisions. Instead of adding more gatekeeping, Otter focuses on guiding clinicians toward evidence-based care — keeping non-concordant decisions below 5% in early deployments. The goal: ditch the adversarial paperwork battle and align both sides around quality and cost.
Prior authorization has long been a flashpoint between payers and providers, and the rise of AI has only intensified the conflict — with both sides deploying algorithms to gain the upper hand. Healthcare startup Otter Health is betting there's a better way. The company launched with $8 million in seed funding co-led by Fika Ventures and Evidenced Capital, with a platform designed to eliminate the need for prior auth altogether by replacing it with real-time, AI-driven clinical quality monitoring.
Rather than automating the existing authorization workflow, Otter gives payers and providers a shared, transparent view of how clinical decisions stack up against evidence-based standards — covering referrals, outpatient procedures, and care transitions. Early deployments show that removing prior authorization, paired with Otter's clinician engagement tools, kept non-concordant care decisions below 5%.
By the Numbers:
Why it matters: As federal rules and state laws push health plans to scale back prior auth for routine services, payers still need visibility into care quality. Otter's approach addresses both problems at once — cutting administrative burden while tackling unnecessary spending that never even enters the authorization pipeline.